ESC: Finerenone Demonstrates CVD Benefit in FIGARO-DKD
Benefit driven by 29% relative reduction in heart failure hospitalization SGLT2 inhibitors were...
ESC 2021 Heart Failure
ESC 2021: A Focus on Heart Failure (eBook)
ESC 2021: A Focus on Heart Failure
Dapagliflozin reduces incidence of sudden death in HFrEF patients
A novel analysis of DAPA-HF investigated the efficacy of dapagliflozin on ventricular arrhythmia (VA), resuscitated cardiac arrest (RCA), and sudden death. The results showed a significantly reduced likelihood for the composite...
GUIDE-HF Trial: Implantable Hemodynamic-Guided HF Device Reduces Hospitalization
The GUIDE-HF trial, presented in a Hot Line Session and simultaneously published in The Lancet, showed benefits of hemodynamic-guided heart failure (HF) management with an implantable device in reducing HF hospitalization [1,2]....
Possible attenuation of hypertrophic cardiomyopathy progression
An American trial investigated the potential of valsartan in slowing the course of disease in hypertrophic cardiomyopathy (HCM). The results showed a significantly positive influence on relative cardiac remodeling in the...
Older patients profit from intensified blood pressure treatment
The randomized controlled STEP trial revealed that lowering the systolic blood pressure (SBP) to below 130 mmHg in patients over 60 years led to a 26% reduction of adverse cardiovascular (CV) events [1]. A target SBP below 130...
EMPEROR-Preserved: landmark trial in heart failure research
EMPEROR-Preserved proved to be a landmark trial in heart failure research. It demonstrated a clinically meaningful benefit of 21% reduction in the primary composite outcome as well as positive results in secondary outcomes with...
ESC: Study Confirms Cutting Salt Intake Can Reduce Strokes and Heart Attacks
SSaSS trial finds mortality benefit for salt substitute vs salt Reducing the use of discretionary...
ESC: How Low Can You Go for Systolic BP in Elderly? Lower Than You Thought
STEP results demonstrate clinical benefit when systolic drops below 130 mmHg An intensive blood...
ESC: Empagliflozin Conquers Heart Failure with Preserved Ejection Fraction… Really
Clinically meaningful benefit seen in patients with EF >40% Among symptomatic heart failure...
Educational Intervention Improves Adherence to HF Guidelines
Investigators used a Web-based recording system, as well as face-to-face regional benchmark analysis and educational meetings, in the BLITZ-HF prospective study to evaluate and improve adherence to heart failure (HF)...
